Organoids shown to speed glycoengineered vaccine development
Using a biomaterials-based organoid, a multi-institution team led by Matt DeLisa of Cornell Engineering was able to assess the strength of the immune response to a glycoengineered vaccine in days... Read more about Organoids shown to speed glycoengineered vaccine development